Solution thermodynamics and solubility of tadalafil in PEG 400 + water co-solvent mixtures at 298.15 to 333.15 K

[1]  M. Sevukarajan,et al.  ENHANCEMENT OF SOLUBILITY OF TADALAFIL BY COCRYSTAL APPROACH , 2016 .

[2]  F. Shakeel,et al.  Thermodynamics-based mathematical model for solubility prediction of glibenclamide in ethanol–water mixtures , 2014, Pharmaceutical development and technology.

[3]  F. Shakeel,et al.  Solubility prediction of indomethacin in PEG 400 + water mixtures at various temperatures , 2013 .

[4]  F. Shakeel,et al.  Solubilization Behavior of Paracetamol in Transcutol–Water Mixtures at (298.15 to 333.15) K , 2013 .

[5]  F. Martínez,et al.  Solution thermodynamics of indomethacin in ethanol + propylene glycol mixtures , 2013 .

[6]  Lei Wang,et al.  Determination and modeling of the solubility and prediction of the dissolution properties of 2, 4-dichlorophenoxyacetic acid in toluene, tetrachloromethane and the binary solvent mixtures of (cyclohexane + ethyl acetate) , 2013 .

[7]  N. Leepipatpiboon,et al.  Thermodynamics of the solubility of 4-acetylbenzoic acid in different solvents from 303.15 to 473.15 K , 2013 .

[8]  Yali Chen,et al.  Determination of the solubility parameter of ionic liquid 1-allyl-3-methylimidazolium chloride by inverse gas chromatography , 2013 .

[9]  M. Samaha,et al.  Tadalafil inclusion in microporous silica as effective dissolution enhancer: optimization of loading procedure and molecular state characterization. , 2011, Journal of pharmaceutical sciences.

[10]  B. P. Reddy,et al.  Validation and stability indicating RP-HPLC method for the determination of tadalafil API in pharmaceutical formulations , 2010 .

[11]  D. Sankar,et al.  UV Spectrophotometric Method for the Estimation of Tadalafil in Bulk and Tablet Dosage form , 2010 .

[12]  Y. Pore,et al.  Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407 , 2009, Acta pharmaceutica.

[13]  G. E. El Maghraby,et al.  Transdermal Delivery of Tadalafil. I. Effect of Vehicles on Skin Permeation , 2009 .

[14]  S. M. Badr-Eldin,et al.  Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  I. Ali,et al.  Determination of tadalafil in pharmaceutical preparation by HPLC using monolithic silica column. , 2005, Talanta.

[16]  D. Hussar.  New drugs of 2003. , 2004, Journal of the American Pharmacists Association : JAPhA.

[17]  R. Strickley.  Solubilizing Excipients in Oral and Injectable Formulations , 2004, Pharmaceutical Research.

[18]  Alexander Apelblat,et al.  Solubilities of l-glutamic acid, 3-nitrobenzoic acid, p-toluic acid, calcium-l-lactate, calcium gluconate, magnesium-dl-aspartate, and magnesium-l-lactate in water , 2002 .

[19]  Alexander Apelblat,et al.  Solubilities ofo-acetylsalicylic, 4-aminosalicylic, 3,5-dinitrosalicylic, andp-toluic acid, and magnesium-DL-aspartate in water fromT=(278 to 348) K , 1999 .

[20]  Alexander Apelblat,et al.  Solubilities ofL-aspartic,DL-aspartic,DL-glutamic,p-hydroxybenzoic,o-anisic,p-anisic, and itaconic acids in water fromT=278 K toT=345 K , 1997 .

[21]  T. Higuchi,et al.  Phase solubility techniques , 1965 .